All In Biotech

Drug Trial Radar · NCT04411836

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine

Effectiveness of Novel Approaches to Radical Cure With Tafenoquine and Primaquine - a Randomized Controlled Trial in P. Vivax Patients

Last checked: Nov 19, 2026Latest source record: Oct 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 960 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

960

Actual

Start

Apr 25, 2021

Primary completion

Sep 30, 2024

Study completion Sep 30, 2024

Sponsor

Lead sponsor
Menzies School of Health ResearchAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Melbourne; National Centre for Parasitology, Entomology and Malaria Control, Cambodia; Mahidol Oxford Tropical Medicine Research Unit; Ethiopian Public Health Institute; Universitas Sumatera Utara; Arba Minch University; Aga Khan University
First posted
Jun 2, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 100 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Health care facility based, randomized, controlled, open label, superiority trial with 3 arms

Conditions

  • Vivax Malaria
  • Plasmodium Vivax
  • Malaria, Vivax
  • Malaria Relapse

Interventions

  • TafenoquineDrug

    patients are treated with schizontocidal treatment plus a single dose of Tafenoquine (TQ).

  • PrimaquineDrug

    patients are treated with schizontocidal treatment plus high dose PQ (total dose 7 mg/kg) unsupervised over 7 days (PQ7)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence risk any P vivax PQ7 / PQ14Time frame: 6 months

Locations

6 sites in 4 countries. Site status is shown where the registry gives one.

  • Chambak Health Center

    Kampong Speu, Cambodia

  • Siem Pang Health Centre

    Stung Treng, Cambodia

  • Kravanh District Hospital

    Pursat, Pursat, Cambodia

  • Arba Minch General Hospital

    Arba Minch, Ethiopia

  • Tanjung Leidong Health Center

    Labuhanbatu, Sumatera, Indonesia

  • Aga Khan Hospital Karachi

    Karachi, Pakistan

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.